Mercer Global Advisors
BOLD

Mercer Global Advisors’s Boundless Bio BOLD Stock Holding History

Mercer Global Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125 Buy
+50
New +$77 ﹤0.01% 5954

Other funds holding BOLD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Mercer Global Advisors's BOLD Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Boundless Bio (BOLD) in Q2 2026: 50 shares worth $125. The stake represents ﹤0.01% of the portfolio and ranks #5954 among its holdings.

11 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Mercer Global Advisors held 50 shares of Boundless Bio worth $125 as of Q2 2026.
  • Boundless Bio was a new Mercer Global Advisors position in Q2 2026.
  • Boundless Bio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5954 holding.
  • 11 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.